ArticleScientific reports2025
Explainable and likelihood aware AI framework for MRI-based pixel-level bladder tumour prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder tumours (BTs) pose significant clinical challenges due to their high recurrence rates and risk of progression to invasive malignancies, which emphasises the need for early and accurate detection. Magnetic resonance imaging (MRI), with its superior soft tissue contrast, is a potential modality for BT detection. To analyse the MRI scans, artificial intelligence (AI) models are increasingly being leveraged. However, these models are often limited by a scarcity of annotated datasets, challenges in pixel-level tumour prediction, and insufficient transparency in predictions. This study introduces the Explainable and Likelihood-Aware AI (ELAAI) framework, designed to address these limitations. Trained solely on annotated normal bladder MRI scans, ELAAI integrates three novel modules: MFA-Net, a robust multi-scale feature aggregation network for bladder segmentation; a refinement step employing adaptive tolerance technique to enhance segmentation of irregularities; and a single-step likelihood prediction network (SLIP-Net), which is a vision transformer with a novel multi-scale deterministic uncertainty (MSDU) head for tumour likelihood prediction. Rigorous evaluation against state-of-the-art (SOTA) models highlights ELAAI's superior performance, enhancing transparency, and reliability in clinical settings by fostering trust in AI-assisted decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.